Unlock instant, AI-driven research and patent intelligence for your innovation.

Mutant strain of coxsackie group a virus type 4 and its application

A technology of coxsackie virus and mutant strains, applied in the field of medicine and biology, to achieve the effect of strong growth ability

Active Publication Date: 2022-03-08
WUHAN INST OF BIOLOGICAL PROD CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the research on the immunogenicity of CV-A4 virus, the pathogenic mechanism, the receptors that the virus binds to cells, and the process and mechanism of virus infection have not yet been elucidated. After the successful establishment of the CV-A4 mouse model, the established mouse model can be used to Research on CV-A4 virus immunogenicity, pathogenic mechanism, combination of virus and cells, process and mechanism of virus infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mutant strain of coxsackie group a virus type 4 and its application
  • Mutant strain of coxsackie group a virus type 4 and its application
  • Mutant strain of coxsackie group a virus type 4 and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1: Breeding of CV-A4-M14 mouse adapted strain

[0043] 1. Cultivate the CV-A4-3179R4 / XY / CHN / 2017 virus strain on RD cells, and adjust the virus titer on RD cells to 1x10 according to the Reed-Muench method 6 TCID 50 / mL (unless otherwise specified, the viral load during the infection process is consistent with this below).

[0044] 2. Infect 10 3-day-old SPF Kunming mice with the virus strain by intracranial injection, 20 μL / mouse.

[0045] 3. Take the brain of a mouse that is on the verge of death, weigh it, prepare a 10% (W / V) homogenate, centrifuge to harvest the supernatant, name it CV-A4-M3, and store it at -20°C.

[0046] 4. Continue to infect 7-day-old suckling mice with the harvested virus according to the same infection method, 30 μL / mouse, and the harvested 7-day-old mouse brain homogenate (named CV-A4-M7).

[0047] 5. Infect 10-day-old suckling mice with the 7-day-old rat brain homogenate (named after CV-A4-M7) harvested at 30 μL / , and take the ...

Embodiment 2

[0052] Embodiment 2: CV-A4-M14-RP3 strain purification

[0053] 1. Plaque purification of CV-A4-M14-RP3 virus clone

[0054] (1) Carry out 10-fold serial dilution of CV-A4-M14-RP3 venom, the dilution range is 10 -1 ~10 -6 .

[0055] (2) Take a 6-well plate with RD cell confluence of 90%-95%, add 200 μL / well of diluted virus suspension, and incubate for 2 hours.

[0056] (3) After incubation, discard the virus solution. After the pre-prepared 2 × low melting point agarose is melted, mix it with 2 × MEM virus maintenance solution 1:1 and spread it in a 6-well plate, 2 mL / well.

[0057] (4) Microscopically check the CPE condition of each well, pick a CPE-positive clone from the well corresponding to the maximum dilution, suspend the virus in 300 μL virus maintenance solution, and blow and mix well.

[0058] (5) Take 100 μL of the harvest solution for ten-fold dilution, and the dilution range is 10 -1 ~10 -4 , repeat the above steps for three consecutive plaque purification...

Embodiment 3

[0064] Example 3: CV-A4-M14-613131 and CV-A4-M14-623131 Whole Genome Sequence Determination

[0065] 1. Viral RNA extraction

[0066] Use the Sangon Bioengineering (Shanghai) Co., Ltd. Column Viral RNA Extraction and Purification Kit (Product No.: B518667) to extract and purify viral RNA.

[0067] 2. cDNA synthesis by reverse transcription

[0068] Reverse transcription synthesis cDNA reaction system is shown in Table 6 and Table 7

[0069] (1) Add the reagents in the PCR tube as shown in Table 6, mix well, place in the PCR instrument, react at 65°C for 5min, and then quickly place it on ice to quench.

[0070] (2) Add reagents as shown in Table 7 to the above reaction solution, mix well and place in PCR instrument, 30°C, 15min; 42°C, 60min; 70°C, 15min.

[0071] Table 6

[0072]

[0073]

[0074] 3. PCR amplification

[0075] (1) Amplification primers: See Table 8 for CV-A4 full sequence determination and extension primers.

[0076] Table 8: CV-A4 whole genome seque...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a mutant strain of Coxsackie group A virus type 4 and its application, including highly virulent mutant strains and weakly virulent mutant strains, and the highly virulent mutant strains contain the following sites alone or in any combination: VP1 Protein: 112D, 3D protein mutations: 3I, 404W, 406K. The attenuated mutant contains the following sites alone or in any combination: VP1 protein: 112E, 3D protein: 3M, 404R, 406R.

Description

technical field [0001] The invention belongs to the field of medical biology, and in particular relates to a Coxsackie group A type 4 virus mutant strain and application thereof. Background technique [0002] Hand-foot-and-mouth disease (HFMD) is a global infectious disease, mainly affecting infants and young children. Common symptoms are fever, rashes on the hands, feet, mouth, and buttocks, maculopapular rashes, and herpes[1]. A small number of severe patients may develop severe neurological complications such as acute aseptic meningitis, encephalitis, and acute flaccid paralysis. Respiratory and circulatory dysfunction such as pulmonary edema and myocarditis can even lead to death [2-3]. HFMD is prevalent in many countries and regions around the world, and affects a wide range. On May 2, 2008, the Ministry of Health of China listed HFMD as a Class C infectious disease stipulated in the Law on the Prevention and Control of Infectious Diseases for management. According t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N7/00A61K39/125A61P31/14A01K67/02C12R1/93
CPCC12N7/00A61K39/12A61P31/14A01K67/02C12N2770/32321C12N2770/32334C12N2770/32331
Inventor 申硕魏真妮吴杰卢佳钱莎莎麦健仪王泽鋆孟胜利
Owner WUHAN INST OF BIOLOGICAL PROD CO LTD